SUCRALFATE IN MANAGEMENT OF STRESS ULCERS: EXPLORING ITS ROLE IN ANGIOGENESIS, PROTECTIVE BARRIER FORMATION, AND NON-SYSTEMIC ACTION
Fuente:
Zenodo
Salvato in:
| Autori principali: | , , , |
|---|---|
| Natura: | Recurso digital |
| Lingua: | inglese |
| Pubblicazione: |
Zenodo
2026
|
| Soggetti: | |
| Accesso online: | |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
| _version_ | 1866901751955718144 |
|---|---|
| author | Dr. Sumit Choudhary Dr. Vaishalee Punj* Dr. Aditya Raj Dr. Anurag Kumar |
| author_facet | Dr. Sumit Choudhary Dr. Vaishalee Punj* Dr. Aditya Raj Dr. Anurag Kumar |
| contents | <p><span>Stress ulcers, or stress-related mucosal damage (SRMD), are a common complication in<span> </span>critically ill patients, characterised by erosions, ulcerations, and inflammation of the mucosa of the upper gastrointestinal (GI) tract. Patients in intensive<span> </span>care<span> </span>units<span> </span>(ICUs),<span> </span>particularly<span> </span>those<span> </span>on mechanical ventilation or with severe burns, trauma, sepsis, or coagulopathy, are at increased risk. Within the first 24 hours after hospitalisation, 75–100% of intensive care unit patients experience stress-related ulcers due to an imbalance between protective and aggressive gastric factors. If left untreated, stress ulcers can lead to significant complications, including gastrointestinal bleeding, increased morbidity, and prolonged hospital stays. Sucralfate binds to negatively charged<span> </span>alternatives due to its unique mechanism of action. It forms a protective barrier over ulcerated mucosa, promotes angiogenesis, and enhances mucosal healing without causing significant changes in<span> </span>gastric pH..<span> </span>This<span> </span>characteristic<span> </span>reduces<span> </span>the<span> </span>likelihood<span> </span>of<span> </span>bacterial overgrowth and infection, making sucralfate a safer option for stress ulcer prophylaxis. Clinical studies have demonstrated that sucralfate effectively prevents stress-related gastrointestinal bleeding while maintaining a favourable safety profile. Sucralfate is added for<span> </span>the treatment regimen<span> </span>along with other acid suppressant drugs like<span> </span>PPIs and H2RAs in the treatment of stress ulcers. Sucralfate, when combined with PPIs and H2RAs, enhances<span> </span>healing<span> </span>and<span> </span>prevents<span> </span>complications by providing protection against acid, pepsin, and bile salts. This<span> </span>combination<span> </span>reduces<span> </span>the<span> </span>risk<span> </span>of bleeding and perforation, leading to faster recovery and shorter<span> </span>hospital<span> </span>stays.<span> </span>However,<span> </span>caution is necessary in patients with renal impairment due<span> </span>to<span> </span>the<span> </span>risk<span> </span>of<span> </span>aluminium<span> </span>accumulation.<span> </span>Given its protective properties, low risk of complications and adverse drug reactions, sucralfate represents a viable and safer add-on therapy for managing stress ulcers in critically ill patients.</span></p> |
| format | Recurso digital |
| id | zenodo_https___doi_org_10_5281_zenodo_19049570 |
| institution | Zenodo |
| language | eng |
| publishDate | 2026 |
| publisher | Zenodo |
| record_format | zenodo |
| spellingShingle | SUCRALFATE IN MANAGEMENT OF STRESS ULCERS: EXPLORING ITS ROLE IN ANGIOGENESIS, PROTECTIVE BARRIER FORMATION, AND NON-SYSTEMIC ACTION Dr. Sumit Choudhary Dr. Vaishalee Punj* Dr. Aditya Raj Dr. Anurag Kumar Sucralfate Angiogenesis Stress Ulcer Gastritis Stress ulcers prophylaxis <p><span>Stress ulcers, or stress-related mucosal damage (SRMD), are a common complication in<span> </span>critically ill patients, characterised by erosions, ulcerations, and inflammation of the mucosa of the upper gastrointestinal (GI) tract. Patients in intensive<span> </span>care<span> </span>units<span> </span>(ICUs),<span> </span>particularly<span> </span>those<span> </span>on mechanical ventilation or with severe burns, trauma, sepsis, or coagulopathy, are at increased risk. Within the first 24 hours after hospitalisation, 75–100% of intensive care unit patients experience stress-related ulcers due to an imbalance between protective and aggressive gastric factors. If left untreated, stress ulcers can lead to significant complications, including gastrointestinal bleeding, increased morbidity, and prolonged hospital stays. Sucralfate binds to negatively charged<span> </span>alternatives due to its unique mechanism of action. It forms a protective barrier over ulcerated mucosa, promotes angiogenesis, and enhances mucosal healing without causing significant changes in<span> </span>gastric pH..<span> </span>This<span> </span>characteristic<span> </span>reduces<span> </span>the<span> </span>likelihood<span> </span>of<span> </span>bacterial overgrowth and infection, making sucralfate a safer option for stress ulcer prophylaxis. Clinical studies have demonstrated that sucralfate effectively prevents stress-related gastrointestinal bleeding while maintaining a favourable safety profile. Sucralfate is added for<span> </span>the treatment regimen<span> </span>along with other acid suppressant drugs like<span> </span>PPIs and H2RAs in the treatment of stress ulcers. Sucralfate, when combined with PPIs and H2RAs, enhances<span> </span>healing<span> </span>and<span> </span>prevents<span> </span>complications by providing protection against acid, pepsin, and bile salts. This<span> </span>combination<span> </span>reduces<span> </span>the<span> </span>risk<span> </span>of bleeding and perforation, leading to faster recovery and shorter<span> </span>hospital<span> </span>stays.<span> </span>However,<span> </span>caution is necessary in patients with renal impairment due<span> </span>to<span> </span>the<span> </span>risk<span> </span>of<span> </span>aluminium<span> </span>accumulation.<span> </span>Given its protective properties, low risk of complications and adverse drug reactions, sucralfate represents a viable and safer add-on therapy for managing stress ulcers in critically ill patients.</span></p> |
| title | SUCRALFATE IN MANAGEMENT OF STRESS ULCERS: EXPLORING ITS ROLE IN ANGIOGENESIS, PROTECTIVE BARRIER FORMATION, AND NON-SYSTEMIC ACTION |
| topic | Sucralfate Angiogenesis Stress Ulcer Gastritis Stress ulcers prophylaxis |
| url | https://doi.org/10.5281/zenodo.19049570 |